scholarly journals The Role of Ras Proteins in Insulin Signal Transduction

1992 ◽  
Vol 24 (05) ◽  
pp. 214-218 ◽  
Author(s):  
J. Maassen ◽  
B. M. T. Burgering ◽  
R. Medema ◽  
A. P. R. M. Osterop ◽  
G. C. M. van der Zon ◽  
...  
1992 ◽  
Vol 303 (1) ◽  
pp. 40-52 ◽  
Author(s):  
Dennis J. Pillion ◽  
Sung-Jin Kim ◽  
Helen Kim ◽  
Elias Meezan

2013 ◽  
pp. 1-1
Author(s):  
Marina Minic ◽  
Nuno Rocha ◽  
Ben Challis ◽  
Matthijs Groeneveld ◽  
Stephen O Rahilly ◽  
...  

2001 ◽  
Vol 193 (2) ◽  
pp. 263-270 ◽  
Author(s):  
Yoshinori Kawazoe ◽  
Tetsuji Naka ◽  
Minoru Fujimoto ◽  
Hidetsugu Kohzaki ◽  
Yoshiaki Morita ◽  
...  

Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1) is known to function as a negative feedback regulator of cytokine signaling, but it is unclear whether it is involved in other biological events. Here, we show that SSI-1 participates and plays an important role in the insulin signal transduction pathway. SSI-1–deficient mice showed a significantly low level of blood sugar. While the forced expression of SSI-1 reduced the phosphorylation level of insulin receptor substrate 1 (IRS-1), SSI-1 deficiency resulted in sustained phosphorylation of IRS-1 in response to insulin. Furthermore, SSI-1 achieves this inhibition both by binding directly to IRS-1 and by suppressing Janus kinases. These findings suggest that SSI-1 acts as a negative feedback factor also in the insulin signal transduction pathway through the suppression of IRS-1 phosphorylation.


1997 ◽  
Vol 130 (1-2) ◽  
pp. 33-42 ◽  
Author(s):  
Ana C.P Thirone ◽  
Carla R.O Carvalho ◽  
Sigisfredo L Brenelli ◽  
Lı́cio A Velloso ◽  
Mario J.A. Saad

1997 ◽  
Vol 272 (36) ◽  
pp. 22884-22890 ◽  
Author(s):  
Paulos Berhanu ◽  
Celia Anderson ◽  
Matt Hickman ◽  
Theodore P. Ciaraldi

2014 ◽  
Vol 2014 ◽  
pp. 1-13 ◽  
Author(s):  
Juhyun Song ◽  
Won Taek Lee ◽  
Kyung Ah Park ◽  
Jong Eun Lee

Vascular dementia is caused by various factors, including increased age, diabetes, hypertension, atherosclerosis, and stroke. Adiponectin is an adipokine secreted by adipose tissue. Adiponectin is widely known as a regulating factor related to cardiovascular disease and diabetes. Adiponectin plasma levels decrease with age. Decreased adiponectin increases the risk of cardiovascular disease and diabetes. Adiponectin improves hypertension and atherosclerosis by acting as a vasodilator and antiatherogenic factor. Moreover, adiponectin is involved in cognitive dysfunction via modulation of insulin signal transduction in the brain. Case-control studies demonstrate the association between low adiponectin and increased risk of stroke, hypertension, and diabetes. This review summarizes the recent findings on the association between risk factors for vascular dementia and adiponectin. To emphasize this relationship, we will discuss the importance of research regarding the role of adiponectin in vascular dementia.


Sign in / Sign up

Export Citation Format

Share Document